ASX Announcements
Visit ASX website for all AdAlta Limited ASX announcements.
Archives
2024 
2023
2022
2021
2020
2019
2018
2017
- AdAlta expands partnership with Alfred Hospital
- Appendix 3B
- Fibrosis symposium presentation material
- Half Yearly Report and Accounts
- Release of Securities from Escrow
- AdAlta Appendix 4C – quarterly
- AdAlta receives Orphan Designation for AD-114
- Updated presentation January 2017
- Positive Pre-clinical Data
2016
- Initial Director’s Interest Notice
- Director Appointment
- Results of AdAlta AGM 2016
- AGM Presentation
- Commercialisation Agreement with Crossbeta Biosciences
- Collaboration Agreement with XL-Protein
- Quarterly Review and Appendix 4C
- Change of Director’s Interest Notice
- Appendix 3B
- AdAlta to present at forthcoming industry conferences
- Update on Orphan Drug Designation
- Notice of Annual General Meeting 2016
- Change of Director’s Interest Notice
- Change of Director’s Interest Notice
- Appendix 3B
- Change of Director’s Interest Notice
- Appendix 4G and Corporate Governance Statement
- Annual Report to shareholders
- Drug Therapy Conferences Presentations
- NDF Research issues research on AdAlta
- Agreement with FujiFilm Diosynth Biotechnologies
- Biotech Meets Broker Presentation
- Receipt of Innovation Connections Grant
- Preliminary Final Report
- Receipt of R&D Tax Incentive
- Becoming a substantial holder
- Becoming a substantial holder
- Becoming a substantial holder
- Becoming a substantial holder
- Investor Presentation
- AdAlta IPO to Accelerate New Therapy for Lung Fibrosis
- Initial Director’s Interest Notice
- Initial Director’s Interest Notice
- Initial Director’s Interest Notice
- Initial Director’s Interest Notice
- Initial Director’s Interest Notice
- Financial accounts to 29 February 2016
- Financial accounts to 30 June 2015
- Financial accounts to 30 June 2014
- Financial accounts to 30 June 2013
- Corporate Governance Policies and Committee Charters
- Employee Share Option Plan
- Constitution AdAlta
- Distribution Schedule
- Top Twenty
- Prospectus dated 8 July 2016
- Information form and checklist
- Appendix 1A
- Market Notice – Admission and commencement of quotation
- Admission to Official List